Praxis Precision Medicines (PRAX) Current Assets (2019 - 2026)

Praxis Precision Medicines' Current Assets history runs 8 years deep, the most recent figure standing at $797.8 million for Q1 2026.

• In Q1 2026, Current Assets rose 139.16% year-over-year to $797.8 million; the TTM figure through Mar 2026 stood at $797.8 million (up 139.16% YoY), while the FY2025 annual figure was $610.9 million, up 51.08% from the prior year.
• Current Assets was $797.8 million for Q1 2026 at Praxis Precision Medicines, up from $610.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $797.8 million in Q1 2026 to a low of $84.9 million in Q4 2023.
• Historically, Current Assets has averaged $277.7 million across 5 years, with a median of $234.5 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Current Assets slumped 61.43% in 2022, then soared 376.4% in 2024.
• A 5-year view of Current Assets shows it stood at $110.8 million in 2022, then declined by 23.42% to $84.9 million in 2023, then jumped by 376.4% to $404.4 million in 2024, then surged by 51.08% to $610.9 million in 2025, then soared by 30.59% to $797.8 million in 2026.
• The last three Current Assets figures came in at $797.8 million (Q1 2026), $610.9 million (Q4 2025), and $273.8 million (Q3 2025), per Business Quant data.